7. Raised ICP (Elevated Intracranial Pressure)

Quick Recap

Neurology System, Protocol 7/12. Unifying framework referenced by Stroke, ICH, SAH, TBI, and Encephalitis/Meningitis protocols for their ICP-elevation complications.

1. Definition

Normal ICP: 5-15 mmHg (a single measurement is not representative — needs trending over 24-72h).

Acute intracranial hypertension (AIH): persistent ICP >20 mmHg for >5 minutes in a non-stimulated patient — the treatment threshold.

Severe/life-threatening: sustained ICP >40 mmHg.

Cerebral Perfusion Pressure (CPP) = MAP − ICP. CPP goal generally 60-70 mmHg following severe TBI (extrapolated as a general ICP-elevation principle across etiologies) — falling below this range increases cerebral ischemia risk.

2. Pathophysiology — Monro-Kellie Doctrine

The skull is a fixed-volume compartment containing brain, blood, and CSF. An increase in any one component's volume (mass lesion, edema, hemorrhage, hydrocephalus) must be compensated by a decrease in another (CSF displacement, venous blood displacement) to keep ICP normal — once compensatory reserve is exhausted, ICP rises steeply and disproportionately to further volume increases. This is why early, small increases in ICP are often well-tolerated while later increases cause rapid, catastrophic decompensation.

Elevated ICP causes harm via two mechanisms: (1) reduced CPP -> global cerebral ischemia, and (2) pressure gradients between cranial compartments (created by dural folds) -> herniation syndromes, the most feared being brainstem compression from mass effect or cerebellar swelling.

3. Immediate Stabilization (ABCDE)

Airway: RSI for GCS <=8 or airway compromise. Induction technique matters for ICP: pretreat with lidocaine 1.5mg/kg 2-3 min before intubation (mitigates laryngoscopy-associated ICP spike); etomidate preferred for minimal BP impact, barring contraindications.

Breathing: Maintain NORMOCARBIA (PaCO2 35-40 mmHg), NOT hyperventilation, as the routine strategy. Hyperventilation causes cerebral vasoconstriction -> reduces ICP but ALSO worsens cerebral perfusion -> NOT recommended for routine ICP management. Reserve hyperventilation (target PaCO2 30-35, brief/transient only, never >6 hours, never prophylactic) strictly as a temporizing bridge for ACUTE herniation symptoms while more definitive therapy (osmotherapy, surgery) is arranged — this distinction between routine avoidance and emergency bridge use is critical and easy to blur.

Maintain normoxia (PaO2 80-120 mmHg, SpO2 >92%).

Circulation — CPP maintenance:

• Maintain euvolemia; avoid hypotension (use normal saline boluses and vasopressors as needed before an ICP monitor is even placed, keeping SBP >100-110 as an interim target)
• Once ICP monitored: titrate MAP (via fluids +/- vasopressors) to maintain CPP 60-70 mmHg
• Avoid hyponatremia and hypotonic IV fluids — both worsen cerebral edema

Disability: frequent neuro checks; consider ICP monitoring (Section 5) if high-risk features present.

Checklist:

4. General Management Goals (Apply to ALL Patients at Risk, Before/Alongside Tiered Therapy)

• Head midline, elevated 30 degrees (ensures smooth jugular venous outflow)
• Temperature <38C (fever worsens cerebral metabolic demand and edema)
• Normoxia and normocarbia as above
• Adequate sedation/analgesia — avoid noxious/painful stimuli that spike ICP; short-acting agents (fentanyl, midazolam, propofol) preferred to allow frequent neuro exams
• Glucose control 80-140 mg/dL
• Seizure prophylaxis for HIGH-RISK patients only (e.g., phenytoin 20mg/kg load, then 5-8mg/kg/day) — note this differs from the NO-prophylaxis rule in the Stroke and ICH protocols; seizure prophylaxis practice is etiology- and risk-stratified, not a blanket ICP-protocol rule
• Early enteral nutrition (within 72h) preferred over parenteral

5. ICP Monitoring — Indications and Modalities

Indicated for: severe TBI (GCS <=8) with clinical/radiologic suspicion of current or impending elevated ICP; decreased consciousness (GCS <=8) from ANY cause with herniation risk; significant IVH or hydrocephalus; any situation where reduced cerebral perfusion cannot be reliably detected without direct monitoring.

Modalities:

• Ventricular catheter (EVD): allows therapeutic CSF drainage in addition to monitoring — generally preferred when hydrocephalus/CSF diversion need coexists
• Parenchymal fiberoptic probe: continuous ICP monitoring, no CSF drainage capability

Routine prophylactic catheter exchange and prophylactic antibiotics for catheter placement are NOT recommended.

Management based on ICP monitoring has been shown to reduce in-hospital and 2-week post-injury mortality in severe TBI specifically — clinical judgment should still guide monitor placement in patients at high deterioration risk even outside strict TBI criteria.

6. Tiered Treatment Algorithm

First-Tier Therapy (ICP >20-22 mmHg sustained)

• Ventilate to normocarbia (PaCO2 ~35 mmHg)
• Adequate sedation +/- pharmacologic paralysis
• Osmotherapy:
• Mannitol: intermittent bolus 0.25-1 g/kg IV — STOP if serum osmolality >320 mOsm/L; avoid in hypovolemia and renal failure (osmotic diuretic effect worsens both)
• Hypertonic saline (3%): bolus ~250mL over 30 min (or loading 10mL/kg then infusion 0.1-1mL/kg/h); 23.4% can be given as a 30mL bolus for rapid effect — withhold if serum sodium >160 mEq/L (some sources cite osmolality ceiling ~360)
• Check serum sodium and osmolality every 6 hours during active osmotherapy regardless of agent chosen
• No definitive evidence establishes mannitol vs hypertonic saline as superior — selection is often institution/patient-factor driven (renal function, volume status, sodium status)
• Consider ventriculostomy to drain 3-5mL CSF if EVD in place
• Brief, transient hyperventilation (PaCO2 30-35) ONLY for acute symptomatic herniation, not as standing therapy
• Increase MAP as needed to maintain CPP

Second-Tier Therapy (ICP persistently elevated despite first-tier)

• Barbiturate coma: thiopental (or pentobarbital) loading 1-5mg/kg IV; if complete response (ICP <20) return to first-tier maintenance or repeat boluses as needed; if incomplete response, start infusion 1-5mg/kg/h titrated to burst suppression EEG pattern (1-2 bursts/min) — requires hemodynamic stability before and throughout, given significant hypotension/myocardial depression risk; propofol may be used for ICP control but is NOT recommended based on mortality/6-month outcome evidence — an important distinction between using it for sedation-level ICP support vs relying on it as definitive second-tier barbiturate-equivalent therapy
• Moderate hypothermia (32-34C) via surface or endovascular cooling for 24-72h, followed by SLOW passive rewarming over 12-24h (rapid rewarming risks rebound ICP spike) — reduces ICP by suppressing cerebral metabolic activity

Third-Tier Therapy (refractory to second-tier, or bridge before overt herniation)

• Decompressive craniectomy (or temporal lobectomy in select cases): removal of a large skull section gives the swollen brain room to expand, reducing ICP and potentially preventing brainstem herniation. Guidelines favor a LARGE frontotemporoparietal craniectomy over a smaller one for better mortality/neurologic outcome. Life-saving but at the cost of higher rates of severe disability among survivors who would otherwise have died — trials (e.g., in large hemispheric stroke) confirm survival benefit when performed within 48h of ictus, but functional outcome benefit is NOT significantly improved — patients who would have died end up severely disabled and dependent instead. This makes an explicit goals-of-care conversation with patient/family essential before pursuing craniectomy, not an afterthought.
• Cerebellar-specific: suboccipital decompressive craniectomy + CSF diversion via ventriculostomy for cerebellar mass lesions causing brainstem compression/hydrocephalus — a more clearly time-critical, less ethically ambiguous indication than supratentorial craniectomy given the direct life-threat from brainstem compression.

7. Etiology-Specific Notes (Cross-References)

• Malignant cerebral (stroke) edema: peaks days 3-5, but severe cases can deteriorate within 48h with 80-90% mortality if untreated; young age, large infarct, and thrombolytic use are risk factors for early deterioration — see Stroke protocol.
• ICH-associated elevated ICP: consider monitoring for GCS <=8, herniation signs, significant IVH/hydrocephalus; seen in ICP >20 in ~70% of one cohort, most common in young patients with supratentorial ICH — see Intracranial Hemorrhage protocol.
• Cryptococcal meningoencephalitis: unique in that SERIAL LUMBAR PUNCTURES (not just standard osmotherapy/CSF diversion) have mortality benefit — see Encephalitis protocol.
• TBI: the etiology with the strongest evidence base for ICP-monitor-guided management improving mortality — see Traumatic Brain Injury protocol for full CPP threshold management table.

8. Organ Support

Osmotherapy, CSF diversion, barbiturate coma, therapeutic hypothermia, decompressive craniectomy per tiered algorithm; mechanical ventilation targeting normocarbia/normoxia; vasopressor support to maintain CPP; standard ICU supportive care.

9. Consultation Matrix

10. Monitoring Framework

Continuous ICP/CPP monitoring once device placed, serum sodium/osmolality every 6h during osmotherapy, continuous EEG if barbiturate coma targeting burst suppression, temperature (active control), frequent neuro checks, watch for rebound ICP on hypothermia rewarming.

11. Complications

Herniation (uncal, central, tonsillar — death if unrecognized/untreated), osmotherapy complications (renal failure/hypovolemia from mannitol, hypernatremia from hypertonic saline), barbiturate-induced hypotension/cardiac depression, hypothermia complications (arrhythmia, coagulopathy, infection risk, rebound ICP on rapid rewarming), craniectomy complications (infection, hydrocephalus, "syndrome of the trephined"), severe disability in craniectomy survivors. Prevention: general management measures (Section 4) applied proactively, careful osmotherapy monitoring, slow controlled rewarming. Rescue: escalation through tiers, decompressive craniectomy as final tier.

12. Escalation & De-escalation

Escalate: ICP >20-22 despite first-tier -> second-tier (barbiturate coma or hypothermia) -> third-tier (decompressive craniectomy) per algorithm, with explicit goals-of-care discussion before third-tier.

De-escalate: ICP controlled and stable -> wean osmotherapy/sedation gradually, wean hypothermia with slow controlled rewarming, transition off barbiturate infusion once burst suppression no longer needed and underlying process resolving.

13. ICU Discharge Criteria

ICP stable/controlled off aggressive tiered therapy, underlying cause addressed (surgical evacuation, CSF diversion, edema resolving), neuro exam stable or at expected post-injury baseline, rehabilitation planning underway.

14. Documentation & Medicolegal Checklist

15. Key Guidelines

Carney N, Totten AM, O'Reilly C, et al. Guidelines for the management of severe traumatic brain injury, 4th ed. Neurosurgery. 2017;80(1):6-15 (Brain Trauma Foundation) — primary evidence base, though applied here as a general ICP-elevation framework across etiologies.

16. Landmark Trials

Hutchinson PJ, Kolias AG, Timofeev IS, et al. Trial of decompressive craniectomy for traumatic intracranial hypertension (RESCUEicp). N Engl J Med. 2016;375:1119-1130 — demonstrated the survival-vs-disability tradeoff central to the craniectomy goals-of-care discussion.

17. Controversies

Mannitol vs hypertonic saline as first-line osmotherapy remains genuinely unresolved by head-to-head evidence — selection is largely patient-factor-driven (renal function, volume status) rather than protocol-mandated. Propofol's role in ICP management is limited to sedation-level support; its use as a definitive barbiturate-equivalent second-tier agent is NOT supported by outcome evidence despite common informal use. The precise threshold and patient selection criteria for decompressive craniectomy (age, timing, laterality) continue to be refined given the disability-vs-mortality tradeoff revealed by RESCUEicp and similar trials. Seizure prophylaxis practice varies meaningfully by underlying etiology (high-risk TBI/mass lesion patients vs the explicit no-prophylaxis stance in Stroke/ICH protocols) and should not be applied as a single blanket rule.

18. References

1. Traumatic Brain Injury and Elevated Intracranial Pressure chapter. Washington Manual of Critical Care, 4th ed, 2025 (Ch. 63).
2. Singhi S. Acute Intracranial Hypertension. ICU Protocols: A Step-wise Approach, 2nd ed. Springer; 2020 (Ch. 37).
3. Carney N, Totten AM, O'Reilly C, et al. Guidelines for the management of severe traumatic brain injury, 4th ed. Neurosurgery. 2017;80(1):6-15.
4. Hutchinson PJ, Kolias AG, Timofeev IS, et al. Trial of decompressive craniectomy for traumatic intracranial hypertension. N Engl J Med. 2016;375:1119-1130.

See also: Stroke, Intracranial Hemorrhage, Subarachnoid Hemorrhage, Encephalitis (Neurology System) for etiology-specific ICP-elevation nuances; Traumatic Brain Injury (Neurology System, forthcoming) for the full TBI-specific CPP management table.